Silicon Laboratories Inc. income statement

In fiscal 2025, Silicon Laboratories Inc. reported revenue of $785m, up 34.3% on the year before, operating income of −$70.5m (a -9.0% margin) and net income of −$64.9m, or −$1.98 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Silicon Laboratories Inc.: income statement, annual
Fiscal year	2009Jan 2010	2010Jan 2011	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Jan 2015	2015Jan 2016	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Jan 2021	2021Jan 2022	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Jan 2026	LTMJul 2026
Revenue	441	493	492	563	580	621	645	698	769	868	474	511	721	1,024	782	584	785	856
Cost of revenue	—	—	—	—	—	—	—	—	315	347	194	216	295	382	322	272	328	337
Gross profit	280	324	298	338	353	379	381	422	454	521	280	295	425	643	461	312	457	519
Research and development	104	124	136	138	158	173	188	200	209	238	206	235	273	332	338	332	353	361
Selling, general and administrative	109	114	112	114	131	154	160	155	160	198	163	167	185	191	147	145	174	201
Operating income	67	87	50	86	64	51	32	66	85	85	−89	−107	−33	119	−24	−165	−71	−43
Interest expense	0	0	0	1	3	3	3	3	—	20	20	34	31	7	6	1	1	1
Income before tax	69	88	52	86	62	49	30	64	77	72	−96	−130	−44	130	−27	−155	−58	−32
Income tax	−4	14	17	23	12	11	1	3	30	−11	7	−15	13	38	8	36	7	7
Net income	73	73	35	64	50	38	30	61	47	84	19	13	2,117	91	−35	−191	−65	−39
Diluted EPS	$1.57	$1.57	$0.79	$1.47	$1.14	$0.87	$0.69	$1.45	$1.09	$1.90	$0.43	$0.28	$47.78	$2.54	−$1.09	−$5.93	−$1.98	−$1.19
Diluted shares (average)	47m	47m	45m	43m	44m	44m	43m	42m	43m	44m	44m	44m	44m	36m	32m	32m	33m	33m
EBITDA	78	98	64	99	78	64	45	79	100	101	−73	−91	−15	142	2	−140	−46	−19

US$ millions unless shown otherwise. Fiscal quarters.

Silicon Laboratories Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Apr 2025	2025 Q2Jul 2025	2025 Q3Oct 2025	2025 Q4Jan 2026	2026 Q1Apr 2026	2026 Q2Jul 2026
Revenue	166	166	178	193	206	208	214	228
Cost of revenue	76	76	80	85	87	76	87	88
Gross profit	90	90	98	108	119	132	127	141
Research and development	83	82	88	88	88	90	89	95
Selling, general and administrative	37	36	42	43	44	46	55	56
Operating income	−30	−29	−32	−23	−12	−3	−17	−11
Interest expense	0	0	0	0	0	0	0	0
Income before tax	−26	−26	−29	−19	−10	−1	−14	−8
Income tax	2	−2	2	3	0	2	2	2
Net income	−29	−24	−30	−22	−10	−3	−16	−11
Diluted EPS	−$0.88	−$0.72	−$0.94	−$0.67	−$0.30	−$0.07	−$0.48	−$0.32
EBITDA	−24	−22	−26	−16	−6	3	−11	−5

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: PLAB vs SLAB HIMX vs SLAB SIMO vs SLAB FORM vs SLAB

More: Semiconductors stocks compared, Technology sector, rankings of US companies

Figures from Silicon Laboratories Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Silicon Laboratories Inc.